Search Content

Dolasetron

Pronounced

"doe-LAS-e-tron"

Common brand names:

Anzemet

Uses

This medication is used to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). Dolasetron works by blocking one of the body's natural substances (serotonin) that causes vomiting.

How to Use This Medication

Take this medication by mouth with or without food as directed by your doctor, usually within 1 hour before the start of chemotherapy.

Children's dosage is based on age and weight. Take this medication exactly as prescribed to get the most benefit from it. Do not increase your dose or use this drug more often or for longer than prescribed.

Tell your doctor if you vomit or feel nauseated.

RxAnswers™ is a copyrighted combined product from TraceGains and First DataBank, Inc.

Drug information is selected from data included with permission and copyrighted by First DataBank, Inc. This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional. Always seek the advice of your healthcare professional if you have any questions about this product or your medical condition. This information is not intended as individual medical advice and does not substitute for the knowledge and judgment of your healthcare professional. This information does not contain any assurances that this product is safe, effective or appropriate for you.

This information is intended only for residents of the United States. Products sold under the same brand names in other countries may contain different ingredients.

Learn more about First DataBank

There are some limitations on the information provided in “Nutrient Interactions.” Do NOT rely solely on the information in this article. Please read the disclaimer.

Learn more about TraceGains, the company.

TraceGains and/or its suppliers make no warranties or representations as to the accuracy or completeness of this content herein or that of any organization referred or linked to within this content and will not be liable for any damages arising out of your access to or use of any information found herein or that of any organization referred to within this content.

Information expires December 2025.